Table 2.
Experimental runs and their observed dependent variables
| Run | Factors
|
Dependent variables
|
||||
|---|---|---|---|---|---|---|
| X1 | X2 | X3 | Y1 | Y2 | Y3 | |
| 1 | 50 | 90 | 40 | 186 | 66.32 | 18.7 |
| 2 | 50 | 80 | 50 | 195 | 63.65 | 15.5 |
| 3 | 30 | 70 | 50 | 136 | 57.37 | 51.2 |
| 4 | 10 | 70 | 40 | 137 | 89.21 | 44 |
| 5 | 30 | 70 | 30 | 181 | 90.74 | 39 |
| 6 | 30 | 90 | 50 | 183 | 77.35 | 29 |
| 7 | 50 | 80 | 30 | 180 | 55.46 | 32.6 |
| 8 | 10 | 80 | 50 | 155 | 94.7 | 30.7 |
| 9 | 10 | 80 | 30 | 134 | 91.7 | 31 |
| 10 | 50 | 70 | 40 | 190 | 86.38 | 31.3 |
| 11 | 30 | 90 | 30 | 172 | 79.72 | 20.3 |
| 12 | 10 | 90 | 40 | 156 | 97.05 | 15.6 |
| 13 | 30 | 80 | 40 | 174 | 86.5 | 36.7 |
| 14 | 30 | 80 | 40 | 158 | 82.5 | 34.3 |
| 15 | 30 | 80 | 40 | 162 | 79.9 | 33.3 |
Notes: Factors studied were percentage of SMV in the SMV-zein mixture (X1), ethanol concentration (X2), and caseinate concentration (X3). The selected dependent variables were mean particle size (Y1), SMV encapsulation efficiency (Y2), and cumulative percentage of drug permeated after 1 hour (Y3).